Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 3/20 | 0.37 |
| ▸ | LAP3 | P28838 | 3/20 | 0.37 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.34 |
| ▸ | PGK2 | P07205 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11758345 | 0.97 | CYP3A4 (0.37) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL1396965 | 0.97 | CYP3A4 (0.37) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL25657143 | 0.91 | TSHR (0.40) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL11142547 | 0.90 | BTN3A1 (0.38) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL11295657 | 0.87 | PLA2G2A (0.42) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL11521477 | 0.87 | PLA2G2C (0.40) | — | |
| SCHEMBL28099467 | 0.87 | PLA2G2C (0.43) | CYP3A4GAAANPEPLAP3MEN1 | |
| SCHEMBL25772792 | 0.87 | ALDH1A1 (0.35) | CYP3A4GAAALDH1A1MEN1KMT2A | |
| SCHEMBL11201428 | 0.85 | CYP3A4 (0.34) | CYP3A4GAAANPEPLAP3ERAP1 | |
| SCHEMBL28584705 | 0.85 | ANPEP (0.37) | CYP3A4GAAANPEPLAP3ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120054044-A | Wide-temperature-range reverse demulsifier and preparation and use methods thereof | 天津阿卡丽环保科技发展有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-115584646-B | Penetrant produced by utilizing industrial side ester | 英德市东鸿化工科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-116768949-A | Compound with anticancer effect based on chemical modification of 3' -deoxyadenosine | 南京工业大学 | 2023-09-19 | — | — | CN | claimed |
| CN-115584646-A | Penetrant produced by using industrial by-product | 英德市东鸿化工科技有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-114813993-A | Method for detecting organic phosphate in urine | 上海交通大学医学院 | 2022-07-29 | — | — | CN | claimed |
| CN-114501989-A | Diamide insecticide composition | FMC公司 | 2022-05-13 | — | — | CN | claimed |
| CN-112210252-B | Fluoric red lead-containing coating | 常州市大使涂料有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-112210252-A | Fluoric red lead-containing coating | 常州市大使涂料有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-112142778-A | Ionic liquid with oil solubility and water solubility as well as preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2020-12-29 | — | — | CN | claimed |
| CN-109971413-B | Preparation method of high-refractive-index LED packaging adhesive material | 北京化工大学 | 2020-10-27 | — | — | CN | claimed |
| EP-1141179-B1 | PHOSPHATE ESTER BASE STOCKS COMPRISING MIXED $i(n)-BUTYL/ISOBUTYL PHOSPHATE ESTERS AND AIRCRAFT HYDRAULIC FLUIDS COMPRISING THE SAME | EXXON RESEARCH ENGINEERING CO (US) | 2004-10-13 | — | — | EP | claimed |
| US-20040054183-A1 | Thienopyridine derivatives, their production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-18 | — | — | US | claimed |
| US-20030130517-A1 | Thienopyridine derivatives , their production and use | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2003-07-10 | — | — | US | claimed |
| US-6537932-B1 | Sterilization wrap is a barrier material which is impermeable to liquids and microorganisms, while being permeable to gases | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-03-25 | — | — | US | claimed |
| EP-1259515-A2 | THIENOPYRIDINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-27 | — | — | EP | claimed |
| WO-2001064685-A2 | THIENOPYRIDINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-09-07 | — | — | WO | claimed |
| EP-1032433-A2 | STERILIZATION WRAP, APPLICATIONS THEREFOR, AND METHOD OF STERILIZING | Kimberly-Clark Worldwide, Inc. (US) | 2000-09-06 | — | — | EP | claimed |
| WO-1999022635-A2 | STERILIZATION WRAP, APPLICATIONS THEREFOR, AND METHOD OF STERILIZING | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1999-05-14 | — | — | WO | claimed |
| US-5677356-A | MIXTURE OF POLYVINYL CHLORIDE RESINS HAVING DIFFERENT PARTICLE SIZES, PLASTICIZER, STABILIZER, FOAMING AGENT, ALKYL PHOSPHATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-10-14 | — | — | US | claimed |
| EP-0672709-A2 | Expandable poly(vinyl chloride) resin composition for powder molding, process and for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-09-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130517-A1 | Thienopyridine derivatives , their production and use | ALK, HRH2, TBXA2R | CYP3A4 55/4885GAA 4072/4885ANPEP 3695/4885 |
| US-20040054183-A1 | Thienopyridine derivatives, their production and use | ALK, HRH2, TBXA2R | CYP3A4 55/4885GAA 4072/4885ANPEP 3695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.